메뉴 건너뛰기
Multiple Sclerosis
Volumn 12, Issue 6, 2006, Pages 677-678
Stem cell therapy in patients with multiple sclerosis
Author keywords

[No Author keywords available]
Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; INTERFERON; NATALIZUMAB; STEROID;
EID: 33846268070     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506073176     Document Type: Editorial
Times cited : (7)
References (7)
  • 1
    • 33748896774 scopus 로고    scopus 로고
    • Cardiac cell therapy - Mixed results from mixed cells
    • Rosenzweig A. Cardiac cell therapy - mixed results from mixed cells. N Engl J Med 2006; 355: 1274-77.
    • (2006) N Engl J Med , vol.355 , pp. 1274-1277
    • Rosenzweig, A.1
  • 2
    • 33745684551 scopus 로고    scopus 로고
    • The therapeutic potential of neural stem cells
    • Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006; 7: 395-406.
    • (2006) Nat Rev Neurosci , vol.7 , pp. 395-406
    • Martino, G.1    Pluchino, S.2
  • 3
    • 3042828420 scopus 로고    scopus 로고
    • Adult stem cells - Reprogramming neurological repair?
    • Rice CM, Scolding NJ. Adult stem cells - reprogramming neurological repair? Lancet 2004; 364: 193-99.
    • (2004) Lancet , vol.364 , pp. 193-199
    • Rice, C.M.1    Scolding, N.J.2
  • 4
    • 23944519424 scopus 로고    scopus 로고
    • Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
    • Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106: 1755-61.
    • (2005) Blood , vol.106 , pp. 1755-1761
    • Zappia, E.1    Casazza, S.2    Pedemonte, E.3    Benvenuto, F.4    Bonanni, I.5    Gerdoni, E.6
  • 5
    • 31544467633 scopus 로고    scopus 로고
    • The window of therapeutic opportunity in multiple sclerosis: Evidence from monoclonal antibody therapy
    • Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 2006; 253: 98-108.
    • (2006) J Neurol , vol.253 , pp. 98-108
    • Coles, A.J.1    Cox, A.2    Le Page, E.3    Jones, J.4    Trip, S.A.5    Deans, J.6
  • 6
    • 4444277781 scopus 로고    scopus 로고
    • The pathogenesis of primary progressive multiple sclerosis: Antibody-mediated attack and no repair?
    • Pender MP. The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair? J Clin Neurosci 2004; 11: 689-92.
    • (2004) J Clin Neurosci , vol.11 , pp. 689-692
    • Pender, M.P.1
  • 7
    • 0344738667 scopus 로고    scopus 로고
    • Effect of relapses on development of residual deficit in multiple sclerosis
    • Lublin FD, Baler M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003; 61: 1528-32.
    • (2003) Neurology , vol.61 , pp. 1528-1532
    • Lublin, F.D.1    Baier, M.2    Cutter, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.